Tag Archives: UK

UK: Saatchi Innovation Bill Still Divisive

 The innovation debate (Why isn’t there more or it? How much should we pay for it? Just what is it anyway?!) remains a lively one in the UK. Lord Saatchi’s Medical Innovation Bill is just one part of this debate. It’s intended to mitigate against so called ‘defensive’ medicine, where clinicians might not prescribe or […]
Posted in Europe, Guest Blog | Also tagged , , , | 4 Comments

New Scottish Medicines Fund Boosted by UK PPRS

 The 2014 Pharmaceutical Price Regulation Scheme (PPRS), the voluntary agreement to cover pricing of branded medicines supplied to the NHS in the UK, included provisions for member companies to pay back to the Department of Health (DH) if spend went over pre-agreed growth rates.  That has translated into £150 million already for the first two […]
Posted in Europe | Also tagged , , , | Leave a comment

UK Postpones Decision on Value-Based Assessment — Again

By Leela Barham. Value-based Pricing (VBP) was first discussed as far back as 2007 by the UK’s consumer authority, the now defunct Office of Fair Trading (OFT).  The general concept of VBP was to set almost provisional prices based on the expected value of new medicines using immature data, with provisions to ‘correct’ the price […]
Posted in Europe, Global, Guest Blog, Op-Ed, pricing | Also tagged , , , , , | Leave a comment

GSK Joins UK–South African Effort to Target Non-communicable Diseases

By Casey McDonald. GSK will weigh in on non-communicable diseases (NCDs) in Africa with a £1m contribution and a commitment of internal R&D expertise supporting researchers from South African institutions, the company announced this month.
Posted in Emerging Markets, Global, healthcare | Also tagged , , , | Leave a comment
  • Categories

  • Meta